key: cord-0908577-rs1p4693
authors: Sadeghi, Neda; Fors, Payton Q.; Eisner, Lillian; Taigman, Jeremy; Qi, Karen; Gorham, Lisa S.; Camp, Christopher C.; O’Callaghan, Georgia; Rodriguez, Diana; McGuire, Jerry; Garth, Erin M.; Engel, Chana; Davis, Mollie; Towbin, Kenneth E.; Stringaris, Argyris; Nielson, Dylan M.
title: Mood and Behaviors of Adolescents With Depression in a Longitudinal Study Before and During the COVID-19 Pandemic
date: 2022-04-19
journal: J Am Acad Child Adolesc Psychiatry
DOI: 10.1016/j.jaac.2022.04.004
sha: b8ec689c5b69a7669045290b818188c838828aa8
doc_id: 908577
cord_uid: rs1p4693

OBJECTIVE: To investigate whether, compared to pre-pandemic levels, depressive and anxiety symptoms in adolescents with depression increased during the pandemic. METHOD: We utilized data from National Institute of Mental Health Characterization and Treatment of Depression (NIMH CAT-D) cohort, a longitudinal case control study that started pre-pandemic. Most of the participants are from the states of Maryland and Virginia in the United States. We compared depressive symptoms (1820 measurements; 519 measurements pre-pandemic and 1302 during the pandemic) and anxiety symptoms (1800 measurements; 508 measurements pre-pandemic and 1292 ratings during the pandemic) of 166 adolescents (109 girls, 96 adolescents with depression) before and during the pandemic. Data was collected during yearly clinical visits, interim four-months follow-up visits, inpatient stays, and weekly outpatient sessions, and additional data collection during the pandemic. Pre-pandemic, healthy volunteers (HVs) had a median of one depressive and anxiety rating (range: 1-3) and adolescents with depression had a median of two ratings (anxiety rating range: 1-25, depressive rating range: 1-26). During the pandemic HVs had a median of eight anxiety ratings and nine depressive ratings (range: 1-13) and adolescents with depression had a median of seven anxiety and depressive ratings (range: 1-29). We also analyzed adolescent- and parent-reported behaviors in the CoRonavIruS Health Impact Survey (CRISIS), totaling 920 self-reported measures for 164 adolescents (112 girls, 92 adolescents with depression). HVs had a median of seven surveys (range: 1-8), and adolescents with depression had a median of five surveys (range: 1-8). RESULTS: Pre-pandemic, adolescents with depression had a mean depressive score of 11.16 (95% CI [10.10, 12.22]) and HVs had a mean depressive score of 1.76 (95% CI [0.40, 3.13]), a difference of 9.40 points (95% CI [7.78, 11.01]). During the pandemic, this difference decreased by 22.6% (2.05 points, 95% CI [0.71, 3.40], P=0.003) due to 0.89 points decrease in severity of scores in adolescents with depression (95% CI [0.08, 1.70], P = 0.032) and 1.16 points increase in healthy individuals’ depressive symptoms (95% CI [0.10 - 2.23], P = 0.032). Compared to their pre-pandemic levels, adolescents with depression reported overall lower anxiety symptoms during the pandemic. Parent-on-child reports also were consistent with these results. CONCLUSION: Contrary to our hypothesis, we found that both depressive and anxiety symptoms were lower for adolescents with depression during the pandemic compared to before. In contrast, the depression scores for the HVs were higher during the pandemic relative to their pre-pandemic ratings; these scores remained much lower than those of adolescents with depression. Clinical trial registration information: Characterization and Treatment of Adolescent Depression; https://clinicaltrials.gov/; NCT03388606.

Depression is a leading cause of disability in adolescence 1 , predicts worse psychiatric outcomes 2 and is strongly associated with suicide 3 . The effects of the coronavirus disease 2019 pandemic on adolescents with psychopathology, and depression in particular, have been a major public health concern 4-9 ; yet results so far remain unclear. Here, we address this gap using a longitudinal cohort of adolescents with and without depression from whom we had pre-pandemic and intra-pandemic follow-up data from the National Institute of Mental Health Characterization and Treatment of Adolescent Depression (NIMH CAT-D) study.

The COVID-19 pandemic is a major environmental stressor with potentially devastating effects on mental health [10] [11] [12] [13] [14] , particularly for those with pre-existing mental health problems 5, [15] [16] [17] . School closures and reductions in social interactions and activities such as sports, accompanied by an increase in media use and decreased sleep, can adversely affect mental health.

Environmental stress is associated with worsening of symptoms and high rates of relapse in adults and adolescents with major depression [18] [19] [20] [21] , as underscored by previous post-disaster studies [22] [23] [24] . These findings are consistent with theories on the interplay of stress and vulnerability 25 .

Yet, there is still a lack of clarity about the pandemic's effect on vulnerable adolescents with depression. Individual studies have shown a wide range of effects on mental health in general with some reporting medium to large effects on the mental health of children and adolescents 10, [26] [27] [28] [29] and others reporting modest or non-significant effects [30] [31] [32] [33] [34] . Meta-analyses of adult studies show the effects of the pandemic on mental health are overall small 7, 8 . In the metaanalysis of longitudinal studies that also looked at changes in mental health symptoms in youth, J o u r n a l P r e -p r o o f the difference between pre-pandemic and pandemic levels was small and not statistically significant 8 . However, in a study of adolescent depression and anxiety symptoms, using data from 12 longitudinal studies 4 , depressive symptoms increased significantly (median of 28%), but anxiety symptoms did not. However, only one sample (n=50 out of 1339 adolescents) consisted of patients with depression and controls, and the patients seemed not to show an increase in depressive symptoms. Moreover, to the best of our knowledge there are no densely-sampled longitudinal studies on the effects of the pandemic on adolescents with clinical depression specifically. Assessments before and after the pandemic are essential to investigate the relationships between the pandemic and subsequent mental health symptoms. Densely-sampled data both allows for more precise estimation of symptom changes and evaluation of changes in the trajectories of symptoms over time. Most of the studies so far have relied on convenience sampling with no pre-pandemic data, and none of the studies that are based on the longitudinal data specifically have looked at adolescents with depression or were densely-sampled enough to examine changes in symptom trajectories before and during the pandemic. Additionally, most of these studies have relied on one informant, mainly youths themselves. However, having the complementary information of both parent and child reports is considered best practice. For example, difficulties with behavior are more apparent to parents, whereas emotional distress is more apparent to children themselves 35, 36 .

To overcome this gap in research, we utilize the NIMH CAT-D cohort, a longitudinal case control study that started pre-pandemic. As part of the CAT-D study, state-of-the-art diagnostic interviews were conducted with each participant and standardized questionnaires were administered to youths and their parents/caretakers on a regular basis. Also, from the onset of the J o u r n a l P r e -p r o o f pandemic, participants reported on COVID-19-related metrics using a specially developed and validated measure 37 .

We ask two main questions. First, is the COVID-19 pandemic associated with changes in depression and anxiety symptoms? We consider average depression and anxiety symptoms, their trajectories, and compare healthy adolescents to adolescents with depression. Based on prior theory, we hypothesized that depression and anxiety symptoms would increase during the pandemic particularly for those with depression.

Second, we ask if the COVID-19 pandemic is associated with changes in participants' key habits (e.g. amount of sleep), behaviors (e.g. exercise), relationships with family and peers, and their worries about their own physical and mental health.

This study was approved by the NIMH institutional review board. All children gave verbal and written assent, and parents gave verbal and written consent.

The data presented here is part of CAT-D, an ongoing longitudinal study at NIMH examining the development and course of depression among adolescents. CAT-D is ongoing and recruiting adolescents via community-practitioner referrals, self-referrals, and responses to advertisements in the community (mainly Maryland, Virginia, and District of Columbia). To be included in the CAT-D study, one must be between ages of 11-17 at the time of enrollment and have a past or current diagnosis of major depressive disorder (MDD) or subthreshold depression (s-MDD), or be included as a healthy volunteer (HV). Additional information about the study and inclusion and exclusion criteria can be found in Supplement 1, available online.

J o u r n a l P r e -p r o o f As part of the CAT-D study, currently adolescents with depression were also offered treatment at NIMH. Prior to the pandemic, inpatient and outpatient treatment were available; after the pandemic, outpatient treatment was offered by remote telehealth. Cognitive-behavioral therapy (CBT) was provided to all who received treatment.

There were 279 participants enrolled in the CAT-D study as of March 11, 2021 (Table S1, available online). Additional inclusion criteria were used to create subsamples for the analyses (Figures S1 and S2, available online). For this study, we included adolescents who had a clinical determination as a HV or as a volunteer with past or current MDD (referred to here as "adolescent with depression") based on clinician ratings on the Kiddie Schedule for Affective Disorders and Schizophrenia-Present and Lifetime Version (KSADS-PL) 38 . In addition, for the analyses comparing measures pre-and during the COVID-19 pandemic, we only included participants who had available data both before and during the pandemic. The World Health Organization declared COVID-19 a pandemic on March 11, 2020, which we use as a reference date for our analyses. We defined pre-pandemic scores as those completed between March 11, 2019 and March 10, 2020, and pandemic scores as those completed between March 11, 2020 and March 11, 2021. In total, 166 participants were included to answer our first question about the association of the pandemic with depression and anxiety symptoms, having at least one (and up to 26) measurement of depression and/or anxiety before the pandemic and at least one (and up to 29) during the pandemic. In total, there were 1820 measurements of depressive symptoms (519 measurements pre-pandemic and 1302 measurements during the pandemic), and 1800 measurements of anxiety symptoms (508 measurements pre-pandemic and 1292 measurements during the pandemic). To answer our second question about changes in the participants' habits and behavior, 164 participants were included, having at least one pandemic depressive or anxiety J o u r n a l P r e -p r o o f rating and two completed CoRonavIruS Health Impact Surveys (CRISIS) for a total of 920 surveys. Demographic information of cohorts used in the analyses are shown in Table 1 . There were no significant differences between the demographic of participants included in these analyses vs. those excluded (Tables S2, S3 , and S5, available online) and their baseline measures prior to the pandemic (Table S4 , available online).

Thirty-two subjects included in the current analyses participated in either inpatient or outpatient treatment; 24 of these participants (75%) finished treatment prior to the start of the pandemic.

Adolescents' birthdate, gender, and race are included in screening procedures during study enrollment. Age is determined based on reported birthdate.

Adolescent depressive symptoms were measured using either the parent-or youth-reported Mood and Feelings Questionnaire (MFQ), two-week short version 39 . The MFQ short version contains 13 items using a 3-point scale with established validity and reliability 39, 40 . Scores range from 0 to 26, with a higher score reflecting greater depressive symptoms.

Adolescent anxiety symptoms were measured using either the parent-or youth-reported Screen for Child Anxiety Related Disorders (SCARED) and the SCARED-short 41 . Five common items using a 3-point scale from the SCARED and SCARED-short were used for scoring. The five common items are: 1-I get really frightened for no reason at all, 2-I am afraid to be alone in the house, 3-People tell me that I worry too much, 4-I am scared to go to school, 5-I am shy. The SCARED was used pre-pandemic and is included in the ongoing CAT-D study protocol, whereas J o u r n a l P r e -p r o o f the SCARED-short was first used during the pandemic to minimize burden on participants and was bundled with each wave of CRISIS forms. Scores range from 0 to 10, with a higher score reflecting higher anxiety symptoms.

We used the CoRonavIruS Health Impact Survey (CRISIS) 37 Responses for amount of sleep per night ranged from less than six hours to more than ten hours (a: less than six hours, b: 6-8 hours, c: 8-10 hours, d: more than 10 hours). We created two binary variables for sleep by combing the above choices. One sleep variable indicating too little sleep (0: more than six hours, 1: less than six hours), and another for too much sleep (0: less than 10 hours, 1: more than 10 hours).

Higher scores for changes in family relationships and friendships indicate worsening of relationships. Items were asked within the context of the two weeks prior to completing the CRISIS. In addition, a total worry composite score was created using five items that inquire Source code and data of individuals who consented to data sharing is available on GitHub https://github.com/nimh-comppsych/COVID19-project.

Analyses and visualizations were completed in R using the lme4, lmerTest, sjPlot, gtsummary, and ggplot2 packages. Linear mixed effects models were generated for continuous outcomes (depressive and anxiety symptoms, worries, and behavioral measures) and a logistic mixed effects model was generated for the binarized sleep variable. Mixed effects models were fitted to the data to answer each question for both youth-reported and parent-reported data. Effect size was calculated using Cohen dz.

Two different models were used to answer whether COVID-19 pandemic has affected adolescent depression and anxiety. In the first model, we compared the mean of healthy adolescents' and adolescents with depression's depressive and anxiety symptoms before and during the pandemic.

This was done by including gender (male or female), group (HV or MDD), period (prepandemic, pandemic), and interaction of period and group as fixed effects, and participant and period as random effects. Second, we examined depressive and anxiety symptoms trajectories before and during the pandemic among adolescents with depression. Participants with at least two time points pre-pandemic and two time points during the pandemic were included for this analysis (n=59, 73% female participants). Gender, time (in months), period (pre-pandemic, pandemic), and interaction of time and period were included as fixed effects. Intercept, time, period, and interaction of time and period were included as random effects.

To answer the second question, we examined how behaviors and worries changed during the pandemic. Participants with at least two pandemic time points were included in this analysis. The main effects and interactions of diagnostic group and time were included as fixed effects and intercept and slope (time) were also included as random effects. Bonferroni correction for multiple comparison was applied for results of COVID-19-related measures, considering P < 0.005 (0.05/10) as significant. who were not participants in inpatient or outpatient treatment at NIMH during the study period and had at least two available data points during the pandemic ( Figure S6 and Table S10, available online).

We did not find that anxiety increased more in adolescents with depression than HVs. Parent-report results for anxiety were similarly non-significant (Table S11, available online).

We evaluated self-reported worries, relationships, and behaviors for differences between adolescents with depression and HVs and differences in trends over time. HVs had an average baseline score of 6.55 on the worries section of the CRISIS questionnaire (95% CI [5.75, 7.36 J o u r n a l P r e -p r o o f exercise, and changes in friendships were not significantly different between adolescents with depression and HVs. We did not find differences in changes over time between adolescents with depression and HVs (Tables 2 and 3; Table S12, available (Table S13 , available online). For trends over time during the pandemic, parents of HVs reported a slight decrease in time spent outdoors (-0.05 points per month, 95% CI [-0.08, -0.02], P = 0.002), but, as with the self-report data, there were no significant differences between the two groups.

It is worth noting that our adolescents with depression included participants with both ongoing and past diagnosis of MDD. To evaluate whether the results are influenced based on the clinical status, we performed a sensitivity analysis. We reran the analyses, including the clinical status in the model (Table S14 , available online). Both groups had higher depression scores compared to HVs. Pre-pandemic, depression scores of adolescents with depression were 12.21 points higher (95% CI [10.35, 14 .07]) and the depression scores of remaining adolescents with depression were 7.35 points higher (95% CI [5.63, 9. Thirty two participants (about a third of our adolescents with depression) received CBT treatment from NIMH clinicians during the study. The majority completed treatment prior to the start of the pandemic (75%, n=24). However, to confirm that inclusion of NIMH-treated subjects did not impact our results we conducted sensitivity analyses. Running the analyses about the effect of COVID-19 on depression and anxiety symptoms restricted to participants who did not enroll in the CBT treatment at NIMH did not alter our main results. The depressive and anxiety ratings for adolescents with depression remained higher in the pre-pandemic period compared to the pandemic period (Table S15 ).

In addition, we have included the demographics of those included vs. excluded in the above analyses in Tables S2-S5 (available online) . There is no significant difference in gender, race, ethnicity, participation region, and first available MFQ and SCARED scores between those who are included in these analyses vs. those who are not. We have also performed additional analyses to assess whether there is any effect of the pandemic on sub-groups (e.g. dividing by age, gender), and we observed similar pattern to the overall group where depressive and anxiety symptoms were lower during the pandemic compared to pre-pandemic for adolescents with depression and higher for HVs. Compared to pre-pandemic, the female HV subgroup and the younger HVs (younger than median age of 16.4 years) had significantly higher depressive and anxiety symptoms during the pandemic. For those with depression, the male subgroup had significantly lower depressive and anxiety symptoms during the pandemic compared to prepandemic. In addition, the older male subgroup with depression (older than median age of 16.4 years) had lower depressive symptoms during the pandemic compared to pre-pandemic (Tables S16 and S17, available online).

The COVID-19 pandemic has raised substantial concerns about child mental health, particularly for those already burdened with psychiatric disorders, such as depression. This study analyzed densely-collected longitudinal data from healthy adolescents and adolescents with depression over the period of the year before the pandemic through its first year. Compared to pre- For anxiety symptoms, comparing pre-pandemic to during the pandemic, we found that adolescents with depression reported less anxiety during the pandemic. In contrast, healthy adolescents reported higher anxiety, though for HVs, this change was not significant in our study. There were also no significant changes in parent-reported anxiety symptoms of HVs, similar to previous findings 26 .

Our study suggests overall lower depression and anxiety symptoms for adolescents with depression during the pandemic compared to pre-pandemic. Possible explanations for this are that adolescents with depression might have felt relief with reduced exposure to stressful social situations (e.g. large social gatherings and school). Also, the general increase in worry in the population might have led adolescents with depression to feel less isolated. It is also important to note that although the change in depressive symptoms, measured by the short MFQ, during pandemic compared to pre-pandemic period is statistically significant, a 0.89-point change is well below the 6-point "reliable change" score for this measure.

This study's strengths include its dense sampling of the cohort before and during the pandemic, its use of clinical diagnoses of depression pre-pandemic, and its inclusion of both self-report and parent-report of mood. Limitations of this study are that most of our participants are from the District of Columbia, Maryland, and Virginia. Such a geographically limited sample may not be representative of other areas. The racial composition of our cohort has less Latino and greater Asian distribution compared to the United States population. Furthermore, participants in our study were under psychiatric care; the effects of the pandemic could be worse for adolescents with depression who did not have access to mental health care, whose access to care was even J o u r n a l P r e -p r o o f 

Global burden of disease in young people aged 10-24 years: a systematic analysis. The Lancet

Depressed adolescents grown up

Severity and Variability of Depression Symptoms Predicting Suicide Attempt in High-Risk Individuals

Longitudinal change in adolescent depression and anxiety symptoms from before to during the COVID-19 pandemic: an international collaborative of 12 samples

Impact of COVID-19 on Mental Health in Adolescents: A Systematic Review

Mental health and the Covid-19 pandemic

The psychological impact of COVID-19 pandemic lockdowns: a review and meta-analysis of longitudinal studies and natural experiments

A systematic review and meta-analysis of longitudinal cohort studies comparing mental health before versus during the COVID-19 pandemic

Patients with mental health disorders in the COVID-19 epidemic

Understanding why the COVID-19 pandemicrelated lockdown increases mental health difficulties in vulnerable young children

The psychological and mental impact of coronavirus disease 2019 (COVID-19) on medical staff and general public -A systematic review and meta-analysis

The prevalence of post-traumatic stress disorder related symptoms in Coronavirus outbreaks: A systematic-review and metaanalysis

Psychological and Behavioral Impact of Lockdown and Quarantine Measures for COVID-19 Pandemic on Children, Adolescents and Caregivers: A Systematic Review and Meta-Analysis

Prevalence of mental health problems during the COVID-19 pandemic: A systematic review and meta-analysis

Adolescent psychiatric disorders during the COVID-19 pandemic and lockdown

Mental burden and its risk and protective factors during the early phase of the SARS-CoV-2 pandemic: systematic review and metaanalyses. Glob Health

Prevalence and Predictors of Anxiety and Depression Symptoms during the COVID-19 Pandemic and Compliance with Precautionary Measures: Age and Sex Matter

Identifying Cognitive and Interpersonal Predictors of Adolescent Depression

Risk for Recurrence in Depression

Life events, depressive relapse and maintenance treatment

A systematic review and meta-analysis on the prevalence of depression in children and adolescents after exposure to trauma

Post-traumatic stress disorder associated with natural and human-made disasters in the World Mental Health Surveys

Mental Health Consequences of Disasters

Mental Health Response to Community Disasters: A Systematic Review

Application of a diathesis-stress model to the interplay of cortical structural development and emerging depression in youth

Longitudinal increases in childhood depression symptoms during the COVID-19 lockdown

Lifestyle and mental health disruptions during COVID-19

Mental health before and during the COVID-19 pandemic: a longitudinal probability sample survey of the UK population

Depressive symptoms, mental wellbeing, and substance use among adolescents before and during the COVID-19 pandemic in Iceland: a longitudinal, population-based study

Perceived stress as mediator for longitudinal effects of the COVID-19 lockdown on wellbeing of parents and children

Increases in depression and anxiety symptoms in adolescents and young adults during the COVID-19 pandemic

The impact of COVID-19 related lockdown measures on self-reported psychopathology and health-related quality of life in German adolescents. Eur Child Adolesc Psychiatry

Mental health before and during the COVID-19 pandemic in two longitudinal UK population cohorts

Risk and Protective Factors for Prospective Changes in Adolescent Mental Health during the COVID-19 Pandemic

Parent and child reports of depressive symptoms in children at low and high risk of depression

Rutter's Child and Adolescent Psychiatry

The Coronavirus Health and Impact Survey (CRISIS) reveals reproducible correlates of pandemic-related mood states across the

Schedule for Affective Disorders and Schizophrenia for School-Age Children-Present and Lifetime Version (K-SADS-PL): Initial Reliability and Validity Data

Development of a short questionnaire for use in epidemiological studies of depression in children and adolescents

Validity of the Short Mood and Feelings Questionnaire in late adolescence

The Screen for Child Anxiety Related Emotional Disorders (SCARED): Scale Construction and Psychometric Characteristics

Is treatment working? Detecting real change in the treatment of child and adolescent depression

Loneliness, physical activity, and mental health during COVID-19: a longitudinal analysis of depression and anxiety in adults over the age of 50 between 2015 and 2020

Depression reported by US

Experiences of American Older Adults with Preexisting Depression During the Beginnings of the COVID-19 Pandemic: A Multicity, Mixed-Methods Study

Students' mental health problems before, during, and after COVID-19 lockdown in Italy

The mental health impact of the COVID-19 pandemic on people with and without depressive, anxiety, or obsessive-compulsive disorders: a longitudinal study of three Dutch case-control cohorts

Social participation, inclusion and mental well-being following SARS-CoV-2 related lockdown restrictions in adults with and without mental disorders. Results from a follow-up study in Germany

What Is the Impact of COVID-19 Pandemic on Patients with Pre-Existing Mood or Anxiety Disorder? An Observational Prospective Study

The Impact of COVID-19 on Adolescent Mental Health: Preliminary Findings From a Longitudinal Sample of Healthy and At-Risk Adolescents